Meeting NewsVideo

VIDEO: Lensar introduces software for astigmatism management, appoints chairman of board

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Nick Curtis, CEO of Lensar, discusses the introduction of the Streamline IV platform with toric IOL alignment guidance, which recently received 510(k) clearance from the FDA. He also discusses the addition of William Link, PhD, as the new chairman of the board at the company.

NEW ORLEANS ― At the Ophthalmology Innovation Summit here, Nick Curtis, CEO of Lensar, discusses the introduction of the Streamline IV platform with toric IOL alignment guidance, which recently received 510(k) clearance from the FDA. He also discusses the addition of William Link, PhD, as the new chairman of the board at the company.

    See more from Ophthalmology Innovation Summit